ST. ANNES PHARMACY LIMITED

Active Cheadle

Dormant Company

0 employees website.com
Healthcare and wellbeing Dormant Company
S

ST. ANNES PHARMACY LIMITED

Dormant Company

Founded 7 Mar 1984 Active Cheadle, United Kingdom 0 employees website.com
Healthcare and wellbeing Dormant Company

Previous Company Names

TESTRELL LIMITED 7 Mar 1984 — 10 Jul 1995
Accounts Submitted 5 Dec 2025 Next due 31 Mar 2027 11 months remaining
Confirmation Submitted 21 Oct 2025 Next due 28 Oct 2026 5 months remaining
Net assets £100 £0 2025 year on year
Total assets £100 £0 2025 year on year
Total Liabilities £0
Charges 4
2 outstanding 2 satisfied

Contact & Details

Contact

Registered Address

No 2 The Courtyard Suite M Earl Road Cheadle Hulme Cheadle Cheshire SK8 6GN

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ST. ANNES PHARMACY LIMITED (01798080), an active healthcare and wellbeing company based in Cheadle, United Kingdom. Incorporated 7 Mar 1984. Dormant Company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2015–2025)

Cash in Bank

£100.00

Net Assets

£100.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Devendra ShahDirectorBritishEngland585 Oct 2009Active

Shareholders

Shareholders (1)

Pharmacy Care Plus Limited
100.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Devendra Shah

British

Active
Notified 6 Apr 2016
Residence England
DOB July 1967
Nature of Control
  • Significant Influence Or Control

Robert George Andrew

British

Active
Notified 6 Apr 2016
Residence England
DOB December 1961
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 outstanding 2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Dec 2025AccountsAnnual accounts made up to 30 Jun 2025
21 Oct 2025Confirmation StatementConfirmation statement made on 14 Oct 2025 with updates
27 Mar 2025MortgageMortgage Satisfy Charge Full
7 Nov 2024Confirmation StatementConfirmation statement made on 28 Oct 2024 with no updates
6 Nov 2024AccountsAnnual accounts made up to 30 Jun 2024
5 Dec 2025 Accounts

Annual accounts made up to 30 Jun 2025

21 Oct 2025 Confirmation Statement

Confirmation statement made on 14 Oct 2025 with updates

27 Mar 2025 Mortgage

Mortgage Satisfy Charge Full

7 Nov 2024 Confirmation Statement

Confirmation statement made on 28 Oct 2024 with no updates

6 Nov 2024 Accounts

Annual accounts made up to 30 Jun 2024

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

5 months ago on 5 Dec 2025

Confirmation statement made on 14 Oct 2025 with updates

6 months ago on 21 Oct 2025

Mortgage Satisfy Charge Full

1 years ago on 27 Mar 2025

Confirmation statement made on 28 Oct 2024 with no updates

1 years ago on 7 Nov 2024

Annual accounts made up to 30 Jun 2024

1 years ago on 6 Nov 2024